Showing 1 of 1 recruiting trials for “Autosomal dominant Charcot-Marie-Tooth disease type 2D”
Personalized Antisense Oligonucleotide for A Single Participant With GARS1 Gene Mutation Associated With Charcot-Marie-Tooth Disease Type 2D (CMT2D)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →